London—Oct. 20, 2014—Tungsten Network is the e‐Invoicing provider for many of the world’s leading pharmaceutical and healthcare companies. The latest organizations to select Tungsten Network include Fresenius Medical Care NA, a U.S.‐based provider of kidney dialysis services and renal care products, and the Dana-Farber Cancer Institute, a provider of cancer treatment and research.
These new customers join the global e‐Invoicing network alongside long‐term practitioners, such as GlaxoSmithKline, and reinforce Tungsten’s strength in the industry. Seven of the 12 largest pharmaceutical companies in the world, ranked by revenue, transact with their suppliers through Tungsten Network.
“The pharmaceutical sector was an early adopter of e‐Invoicing with our first customer from the industry joining the network in 2004,” said Edmund Truell, Tungsten Group CEO.